Preferential Issue
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.5 pts more than Nifty Microcap 250 and 5.0 pts more than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vaxfab Enterprises' board approved a preferential issue of 2,54,94,763 fully convertible warrants at Rs. 21.02 per warrant (face value Rs. 10 + premium of Rs. 11.02), aggregating to about Rs. 53.59 crores. The warrants are offered to 58 public allottees (mostly individuals and a few LLPs/firms), with 25% payable upfront and the balance within 18 months on conversion. The board also approved raising the authorised share capital from Rs. 9.3 crores to Rs. 35 crores to accommodate this and future issuances, subject to shareholder approval. Separately, the company will acquire 100% stakes in three entities — Aarsha International (travel/tours, FY25 turnover ~Rs. 15.86 cr), Satvat Agro LLP (paper/packaging) and Eklingji Tradelink (trading) — making them wholly owned subsidiaries; this is flagged as a related party transaction. The 42nd AGM is scheduled for 30th September 2025, and a new internal auditor and company secretary have been appointed.
Existing shareholders will face dilution once the warrants are exercised, but the capital is being raised at a premium and appears aimed at funding acquisitions and expansion into travel, paper, and trading businesses. The related-party acquisition tag and addition of multiple unrelated businesses may warrant close scrutiny by investors.